As a leading Total Hip Implants Supplier and Exporter, we recognize that the landscape of orthopedic surgery is shifting from traditional implant provision to comprehensive "Value-Based Healthcare" solutions. Modern Total Hip Arthroplasty (THA) is no longer just about the hardware; it’s about the synergy between biocompatible materials, precision instrumentation, and long-term clinical survivability.
The future of hip implants lies in additive manufacturing (3D Printing) and advanced tribology. We are pioneering the use of highly cross-linked polyethylene (HXLPE) and ceramic-on-ceramic interfaces to minimize wear debris and osteolysis. Our R&D focus includes bioactive surface treatments that promote rapid osseointegration, reducing the "Primary Stability" gap in cementless fixations.
The global aging population demands scalable orthopedic solutions. We provide integrated kits that streamline the surgical workflow, from preoperative planning with AI-driven imaging to modular implant systems that cater to diverse patient anatomies across South America, SE Asia, and Western Europe.
Navigating the EU MDR (Medical Device Regulation) and FDA 510(k) landscapes requires more than just paperwork—it requires a culture of quality. Our products maintain rigorous ISO 13485 and CE certifications, ensuring that every batch exported meets the highest international safety thresholds.
Our 29,523㎡ facility represents the pinnacle of China's Medical Manufacturing 4.0. By integrating automated CNC machining centers with real-time QA monitoring, we achieve a precision tolerance within microns. This automation doesn't just increase capacity—it ensures traceability from raw titanium ingots to the final sterile package, providing our global partners with the resilience needed in a volatile market.
Years Experience
R&D Engineers
QC Inspectors
Market in S. America
We prioritize ethically sourced medical-grade titanium and cobalt-chrome alloys, ensuring that our supply chain is as sustainable as it is efficient. For global wholesalers and brand businesses, this means reduced lead times and a stable price-to-quality ratio that outcompetes traditional Western manufacturers.
| Attribute | Details |
|---|---|
| Registration Date | 2004-11-03 (22 Years in Industry) |
| Production Space | 29,523 ㎡ State-of-the-Art Facility |
| Certifications | ISO 13485, CE 93/42/EEC, MDR (Medical Device Regulation) |
| R&D Strength | 59 Graduate Engineers; Customization (Sample/Graphic) |
| Quality Control | 100% Product Inspection; 69 Specialized QC Inspectors |
| Key Markets | South America (30%), Southeast Asia (20%), Western Europe (20%) |
KaiSo has established a complete Quality Assurance System to continuously fulfil the requirements according to ISO9001, 13485, CE, ranging from material procurement to design development and automated production processes.
KaiSo Medical
